Forest Laboratories, Inc. and its subsidiaries, engage in the development, manufacture, and sale of branded and generic forms of ethical drug products, as well as nonprescription pharmaceutical products. Its principal products include Lexapro, a single isomer version of Celexa for the treatment of major depression; Namenda, a NMDA antagonist for the treatment of moderate to severe Alzheimer's disease; Benicar, an angiotensin receptor blocker for the treatment of hypertension; Campral for the maintenance of alcohol abstinence; and Combunox for the short-term management of acute, and moderate-to-severe pain. The company also offers Sudocrem, a topical preparation for the treatment of diaper...